Marc Wiesenberger
Stock Analyst at B. Riley Securities
(3.02)
# 1,101
Out of 4,829 analysts
32
Total ratings
62.96%
Success rate
52.03%
Average return
Main Sectors:
Stocks Rated by Marc Wiesenberger
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SMLR Semler Scientific | Downgrades: Neutral | $60 → $45 | $34.79 | +29.35% | 7 | Nov 2, 2022 | |
OPRX OptimizeRx | Maintains: Buy | $71 → $56 | $9.99 | +460.56% | 1 | Jul 20, 2022 | |
CLPT ClearPoint Neuro | Reinstates: Buy | $15 | $14.11 | +6.31% | 2 | Apr 5, 2022 | |
OESX Orion Energy Systems | Downgrades: Neutral | $8.5 → $5 | $0.67 | +641.29% | 5 | Nov 10, 2021 | |
ZYXI Zynex | Upgrades: Buy | $18 | $2.07 | +756.52% | 9 | Jul 16, 2021 | |
NSIT Insight Enterprises | Maintains: Buy | $67 → $64 | $132.89 | -52.22% | 3 | May 11, 2020 | |
LPTH LightPath Technologies | Maintains: Buy | $2.1 → $3.25 | $2.44 | +33.20% | 5 | May 8, 2020 |
Semler Scientific
Nov 2, 2022
Downgrades: Neutral
Price Target: $60 → $45
Current: $34.79
Upside: +29.35%
OptimizeRx
Jul 20, 2022
Maintains: Buy
Price Target: $71 → $56
Current: $9.99
Upside: +460.56%
ClearPoint Neuro
Apr 5, 2022
Reinstates: Buy
Price Target: $15
Current: $14.11
Upside: +6.31%
Orion Energy Systems
Nov 10, 2021
Downgrades: Neutral
Price Target: $8.5 → $5
Current: $0.67
Upside: +641.29%
Zynex
Jul 16, 2021
Upgrades: Buy
Price Target: $18
Current: $2.07
Upside: +756.52%
Insight Enterprises
May 11, 2020
Maintains: Buy
Price Target: $67 → $64
Current: $132.89
Upside: -52.22%
LightPath Technologies
May 8, 2020
Maintains: Buy
Price Target: $2.1 → $3.25
Current: $2.44
Upside: +33.20%